“springworks-therapeutics” Archives

in
Entry Author Date Location
Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs 05/08/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M 09/12/19 San Francisco
As New CEO of Cerevel, Coles Moves From One Neuro Startup to Another 09/09/19 Boston
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs 08/16/19 New York
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
SpringWorks, Armed with Ex-Pfizer Cancer Drugs, Reloads with $125M 04/01/19 New York
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away 09/07/18 National
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life 09/25/17 New York
Page 1 of 1